Sound Income Strategies »

4d Molecular Therapeutics In shares owned by Sound Income Strategies

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Sound Income Strategies from 13F filings

Historical chart of Sound Income Strategies investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Sound Income Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Sound Income Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $189 25 7.56

More positions owned by Sound Income Strategies

Sixth Street Specialty Lending Cef (TSLX)
Ares Capital Corp Cef (ARCC)
Hercules Capital Cef (HTGC)
Golub Cap Bdc Cef (GBDC)
Blue Owl Capital Corporation Cef (OBDC)
Ishares 0-5 Year High Yield Corporate Bond Etf Etf (SHYG)
Pennantpark Floating Rate Cap Cef (PFLT)
Vaneck Emerging Markets High Yield Bond Etf Etf (HYEM)
Blackstone Secd Lending Cef (BXSL)
Ishares J.p. Morgan Em High Yield Bond Etf Etf (EMHY)
Sound Enhanced Fixed Income Etf Etf (FXED)
Citigroup Stock (C)
Omnicom Group Stock (OMC)
Enbridge Stock (ENB)
Greif Inc Cl B Stock (GEF.B)

View all positions for Sound Income Strategies

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In